This effort involves the recruitment of additional patients with metabolic liver diseases, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), which represent an increasing trend in liver disease prevalence in the future.
← all excerpts
Machine learning-based cfDNA fragmentation profiling using automated capillary electrophoresis for early detection of hepatocellular carcinoma.
1
—
—